OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum.
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Oxaliplatin
Related studies linked through entity extraction aliases.
Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Gemcitabine Plus Erlotinib Versus Erlotinib Plus Gemcitabine Plus Oxaliplatin, in Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE4
Phase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study Of Sunitinib In Combination With Cisplatin/Capecitabine Or Oxaliplatin/Capecitabine In Patients With Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Leucovorin, Fluorouracil, Cetuximab, and Oxaliplatin in Treating Patients With Stage IV Colorectal Cancer and Liver Metastases That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Capecitabine, Irinotecan, and Oxaliplatin in Treating Patients With Metastatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement
- Status
- TERMINATED
- Phase
- PHASE2
Gemcitabine and Oxaliplatin in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/II Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ)
- Status
- COMPLETED
- Phase
- PHASE2